Hello Leesa,

You would include your consortium F&A in 7b and 8b.

Valerie

Valerie A. Blake
Assistant Director
North Shore-Long Island Jewish Health System
Office of Grants and Contracts
5 Dakota Drive, Suite 307
Lake Success, NY  11042
Tel:  (516) 719-3100
Fax: (516) 719-3110
xxxxxx@nshs.edu

-----Original Message-----
From: Research Administration List [mailto:xxxxxx@HRINET.ORG]On Behalf
Of Pamela Miller
Sent: Monday, May 23, 2005 1:32 PM
To: xxxxxx@HRINET.ORG
Subject: [RESADM-L] NIH Modular Grants

I am passing this question on from a colleague at Seattle University:

Question re: NIH modular grant:

Now that the  consortium F & A is separate from the direct costs on the
budget justification page, where do we include the consortium F & A on
the cover sheet?  Would it be included in the direct costs in 7a and 8a
or would we include the consortium F & A in the total costs in 7b and
8b?

Thank you for your help!

Leesa Brown
Sponsored Research Officer
Seattle University
206-296-6161

Pamela F. Miller, Ph.D.
Director, Office of Sponsored Projects
The University of San Francisco
2130 Fulton Street
San Francisco, CA  94117-1080
TEL  415-422-5368
FAX  415-422-6222
EMAIL  xxxxxx@usfca.edu

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================
_____________________________________________________________________

The information contained in this electronic e-mail transmission
and any attachments are intended only for the use of the individual
or entity to whom or to which it is addressed, and may contain
information that is privileged, confidential and exempt from
disclosure under applicable law. If the reader of this communication
is not the intended recipient, or the employee or agent responsible
for delivering this communication to the intended recipient, you
are hereby notified that any dissemination, distribution, copying
or disclosure of this communication and any attachment is strictly
prohibited. If you have received this transmission in error, please
notify the sender immediately by telephone and electronic mail,
and delete the original communication and any attachment from any
computer, server or other electronic recording or storage device
or medium. Receipt by anyone other than the intended recipient is
not a waiver of any attorney-client, physician-patient or other
privilege. Thank you.

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================